Moderna, Inc.(MRNA)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

MRNA Moderna, Inc.

交易中 04-24 14:51:48 EDT

108.29

+0.40

+0.37%

最高111.23	最低106.64	成交量249.50万
今开111.00	昨收107.89	日振幅4.25%
总市值414.62亿	流通市值374.28亿	总股本3.83亿
成交额2.71亿	换手率0.72%	流通股本3.46亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"MRNA","market":"US","secType":"STK","nameCN":"Moderna, Inc.","latestPrice":108.29,"timestamp":1713984702085,"preClose":107.89,"halted":0,"volume":2494992,"delay":0,"floatShares":345631168,"shares":382879612,"eps":-12.340314,"marketStatus":"交易中","marketStatusCode":2,"change":0.4,"latestTime":"04-24 14:51:48 EDT","open":111,"high":111.23,"low":106.64,"amount":270983426.41248,"amplitude":0.042543,"askPrice":108.29,"askSize":13,"bidPrice":108.21,"bidSize":4,"shortable":3,"etf":0,"ttmEps":-12.340314,"exchange":"NASDAQ","tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1713988800000},"adr":0,"listingDate":1544158800000,"adjPreClose":107.89,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":111.1,"preClose":107.89,"latestTime":"09:29 EDT","volume":143316,"amount":15947861.95476,"timestamp":1713965399999},"postHourTrading":{"tag":"盘后","latestPrice":107.98,"preClose":107.89,"latestTime":"19:59 EDT","volume":170276,"amount":18370040.321,"timestamp":1713916797914},"volumeRatio":1.250693},"requestUrl":"/m/hq/s/MRNA/wiki","defaultTab":"wiki","newsList":[{"id":"2429451709","title":"Moderna(MRNA.US)拥抱“AI+医疗”浪潮! 联手OpenAI加速药物开发","url":"https://stock-news.laohu8.com/highlight/detail?id=2429451709","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2429451709?lang=zh_cn&edition=full","pubTime":"2024-04-24 22:09","pubTimestamp":1713967762,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，凭借基于m-RNA技术的新冠疫苗而闻名全球的生物技术领域领导者Moderna当地时间周三宣布，该公司已经与ChatGPT开发商OpenAI进行合作，将在其整个业务线中部署ChatGPT Enterprise，以全面加速该公司的药物研发进程。此前Recursion Pharmaceuticals已经于2023年与AI芯片霸主英伟达进行全面合作，共同开发基于人工智能技术的药物开发进程。获“AI教父”认证“黄金赛道”!","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1109321.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2429124361","title":"中信建投 | 2024年一季度疫苗行业纵览：Moderna布局多领域疫苗管线，国内部分二类苗批签发放量","url":"https://stock-news.laohu8.com/highlight/detail?id=2429124361","media":"中信建投证券研究","top":-1,"share":"https://www.laohu8.com/m/news/2429124361?lang=zh_cn&edition=full","pubTime":"2024-04-24 07:38","pubTimestamp":1713915489,"startTime":"0","endTime":"0","summary":"文｜贺菊颖刘若飞2024年3月，Moderna召开疫苗日活动，公布了其在mRNA疫苗领域的研发布局和最新进展。批签发方面，24Q1国内疫苗行业整体批签发727批次，带状疱疹疫苗、肺炎疫苗等二类苗产品批签发同比快速增长。2）带状疱疹疫苗：国内两款疫苗上市，竞争格局较为理想。7）流感疫苗：国内多款疫苗上市，临床阶段管线众多。2024年一季度，疫苗行业公司预计整体呈现平稳增长趋势。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404240745338b4c649b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404240745338b4c649b&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2429921256","title":"莫德纳跌1.40% 股价跌破100美元大关","url":"https://stock-news.laohu8.com/highlight/detail?id=2429921256","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2429921256?lang=zh_cn&edition=full","pubTime":"2024-04-22 21:36","pubTimestamp":1713792983,"startTime":"0","endTime":"0","summary":"北京时间2024年04月22日21时36分，莫德纳股票出现异动，股价大幅下跌1.40%。截至发稿，该股报100.00美元/股，成交量10.4752万股，换手率0.03%，振幅2.78%。莫德纳股票所在的生物技术行业中，整体涨幅为0.45%。莫德纳公司简介：莫德纳是一家商业阶段的生物技术公司，成立于 2010 年，并于 2018 年 12 月进行首次公开募股。该公司的 mRNA 技术通过其 COVID-19 疫苗迅速得到验证，该疫苗于 2020 年 12 月在美国获得批准。截至 2023 年中期，莫德纳拥有处于临床试验中的39个mRNA开发候选物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042221362487e827f5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042221362487e827f5&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428594182","title":"莫德纳跌3.32% 股价跌破100美元大关","url":"https://stock-news.laohu8.com/highlight/detail?id=2428594182","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2428594182?lang=zh_cn&edition=full","pubTime":"2024-04-18 21:48","pubTimestamp":1713448111,"startTime":"0","endTime":"0","summary":"北京时间2024年04月18日21时48分，莫德纳股票出现异动，股价急速跳水3.32%。截至发稿，该股报100.00美元/股，成交量19.8214万股，换手率0.05%，振幅2.51%。莫德纳股票所在的生物技术行业中，整体跌幅为0.66%。莫德纳公司简介：莫德纳是一家商业阶段的生物技术公司，成立于 2010 年，并于 2018 年 12 月进行首次公开募股。该公司的 mRNA 技术通过其 COVID-19 疫苗迅速得到验证，该疫苗于 2020 年 12 月在美国获得批准。截至 2023 年中期，莫德纳拥有处于临床试验中的39个mRNA开发候选物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404182148317a53cad5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404182148317a53cad5&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426634442","title":"因新冠疫苗销量下滑，Moderna暂停肯尼亚疫苗厂计划","url":"https://stock-news.laohu8.com/highlight/detail?id=2426634442","media":"智通财经网","top":-1,"share":"https://www.laohu8.com/m/news/2426634442?lang=zh_cn&edition=full","pubTime":"2024-04-12 01:10","pubTimestamp":1712855439,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，随着新冠疫苗销量下降，美国生物技术公司 Moderna暂停了在肯尼亚建设疫苗工厂的计划。据了解，此前，Moderna与肯尼亚政府达成了一项协议，计划投资约2亿美元建设年产量达5亿剂疫苗的工厂。然而，在面临新冠疫苗销量下降的情况下，Moderna决定暂停购买肯尼亚Tatu City经济区的地块。而Moderna的这一决定突显了全球疫苗市场在新冠疫情后期的变化和挑战，同时也反映了全球疫情应对策略的演变。","market":"us","thumbnail":"https://static.tigerbbs.com/6e474d690ea02c536f0fd4c03fc3ddef","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/6e474d690ea02c536f0fd4c03fc3ddef"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1101420.html","is_publish_highlight":true,"gpt_icon":1},{"id":"2426255483","title":"Needham：重申Moderna(MRNA.US)持有评级。","url":"https://stock-news.laohu8.com/highlight/detail?id=2426255483","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2426255483?lang=zh_cn&edition=full","pubTime":"2024-04-11 19:46","pubTimestamp":1712835994,"startTime":"0","endTime":"0","summary":"Needham：重申Moderna(MRNA.US)持有评级。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404111946378b101d55&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404111946378b101d55&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426175994","title":"Moderna盘中异动，股价跌超5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2426175994","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2426175994?lang=zh_cn&edition=full","pubTime":"2024-04-11 00:11","pubTimestamp":1712765519,"startTime":"0","endTime":"0","summary":"Moderna是一家商业阶段的生物技术公司。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240411001159791fb080&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240411001159791fb080&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426345969","title":"癌症疫苗对黑色素瘤和头颈癌展现双重效力 Moderna(MRNA.US)一度飙升10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2426345969","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2426345969?lang=zh_cn&edition=full","pubTime":"2024-04-10 16:39","pubTimestamp":1712738357,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，美东时间周二，Moderna盘中一度涨超10%，达到三个月以来的最高点。在之前的一项中期研究中，这种疫苗展现出治疗黑色素瘤的潜力。据悉，Keytruda被用于治疗多种类型的癌症，包括不可手术的或转移性黑色素瘤、某些类型的非小细胞肺癌、头颈部癌症、霍奇金淋巴瘤等。在圣地亚哥举行的美国癌症研究协会年会上，有22名患者接受了这种名为mRNA-4157的疫苗与Keytruda的联合治疗，并报告了相关数据。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1100559.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2426831110","title":"杰富瑞投资银行：重申Moderna(MRNA.US)评级，由买入调整至买入评级, 目标价125.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2426831110","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2426831110?lang=zh_cn&edition=full","pubTime":"2024-04-10 00:25","pubTimestamp":1712679915,"startTime":"0","endTime":"0","summary":"杰富瑞投资银行：重申Moderna(MRNA.US)评级，由买入调整至买入评级, 目标价125.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240410002518875ab078&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240410002518875ab078&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426711269","title":"更新版 1-在早期研究中，Moderna疫苗显示出对头颈癌的治疗效果","url":"https://stock-news.laohu8.com/highlight/detail?id=2426711269","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2426711269?lang=zh_cn&edition=full","pubTime":"2024-04-10 00:03","pubTimestamp":1712678602,"startTime":"0","endTime":"0","summary":"Yee说，与之前单独测试Keytruda的试验相比，这种联合疗法在延长生存期方面显示出强大的优势。周一在圣地亚哥举行的美国癌症研究协会年会上，报告了22名接受mRNA-4157疫苗与Keytruda联合治疗的患者的数据。Moderna公司表示，该疫苗组合显示出激活患者免疫反应的证据，而且在研究中发现其安全性和耐受性良好。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2426119284","title":"Moderna盘中大涨，个性化癌症疫苗在早期研究中显示出疗效","url":"https://stock-news.laohu8.com/highlight/detail?id=2426119284","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2426119284?lang=zh_cn&edition=full","pubTime":"2024-04-09 23:23","pubTimestamp":1712676202,"startTime":"0","endTime":"0","summary":"这种疫苗旨在训练免疫系统识别和攻击癌细胞中的特定突变。","market":"us","thumbnail":"https://static.tigerbbs.com/6658a41cf123d7c6c01ab308bd2eb08b","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/6658a41cf123d7c6c01ab308bd2eb08b"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":true,"gpt_icon":0},{"id":"2426119409","title":"BUZZ-头颈癌疫苗数据公布后，Moderna公司业绩上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2426119409","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2426119409?lang=zh_cn&edition=full","pubTime":"2024-04-09 23:22","pubTimestamp":1712676170,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 ))    4月9日 - ** Moderna   股价上涨10.3%，达到115.89美元的三个月高点** 该公司基于mRNA的癌症疫苗与默克公司  的抗癌药物Keytruda一起使用，在一项早期试验中，27.3%的头颈癌患者肿瘤缩小或消失。** 经纪公司杰富瑞（Jefferies）称，数据显示该药物有可能在皮肤癌以外的其他疾病中发挥作用** 股价今年累计上涨 14.2","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2426197894","title":"莫德纳盘中异动 急速拉升5.02%报110.37美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2426197894","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2426197894?lang=zh_cn&edition=full","pubTime":"2024-04-09 21:44","pubTimestamp":1712670299,"startTime":"0","endTime":"0","summary":"北京时间2024年04月09日21时44分，莫德纳股票出现异动，股价快速上涨5.02%。截至发稿，该股报110.37美元/股，成交量62.8908万股，换手率0.16%，振幅4.23%。莫德纳股票所在的生物技术行业中，整体涨幅为0.01%。莫德纳公司简介：莫德纳是一家商业阶段的生物技术公司，成立于 2010 年，并于 2018 年 12 月进行首次公开募股。该公司的 mRNA 技术通过其 COVID-19 疫苗迅速得到验证，该疫苗于 2020 年 12 月在美国获得批准。截至 2023 年中期，莫德纳拥有处于临床试验中的39个mRNA开发候选物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240409214459861e43b0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240409214459861e43b0&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2424214938","title":"莫德纳跌3.51% 股价跌破100美元大关","url":"https://stock-news.laohu8.com/highlight/detail?id=2424214938","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2424214938?lang=zh_cn&edition=full","pubTime":"2024-04-04 00:38","pubTimestamp":1712162311,"startTime":"0","endTime":"0","summary":"北京时间2024年04月04日00时38分，莫德纳股票出现异动，股价急速下跌3.51%。截至发稿，该股报99.98美元/股，成交量153.592万股，换手率0.40%，振幅4.67%。莫德纳股票所在的生物技术行业中，整体涨幅为0.29%。莫德纳公司简介：莫德纳是一家商业阶段的生物技术公司，成立于 2010 年，并于 2018 年 12 月进行首次公开募股。该公司的 mRNA 技术通过其 COVID-19 疫苗迅速得到验证，该疫苗于 2020 年 12 月在美国获得批准。截至 2023 年中期，莫德纳拥有处于临床试验中的39个mRNA开发候选物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240404003831861e35b3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240404003831861e35b3&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2422964100","title":"更新版 1-Moderna 从 Blackstone Life Sciences 获得 7.5 亿美元，用于开发流感疫苗","url":"https://stock-news.laohu8.com/highlight/detail?id=2422964100","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2422964100?lang=zh_cn&edition=full","pubTime":"2024-03-27 18:59","pubTimestamp":1711537155,"startTime":"0","endTime":"0","summary":"作为协议的一部分，Blackstone Life Sciences 将获得商业里程碑付款和低个位数的版税，COVID-19 疫苗生产商表示。Moderna 股价在盘前交易中上涨超过 2%。Moderna 计划今年向监管机构提交申请。其 RSV 疫苗预计将于今年在美国上市。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2422966008","title":"Moderna 从 Blackstone Life Sciences 获得 7.5 亿美元资金，用于开发流感疫苗","url":"https://stock-news.laohu8.com/highlight/detail?id=2422966008","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2422966008?lang=zh_cn&edition=full","pubTime":"2024-03-27 18:30","pubTimestamp":1711535414,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 ))    路透社3月27日 - Moderna    周三表示，已与私募股权公司 Blackstone 的    生命科学投资平台达成协议，将出资 7.5 亿美元开发其 mRNA 流感疫苗。这家 COVID-19 疫苗生产商称，作为协议的一部分，Blackstone Life Sciences 将获得商业里程碑付款和低个位数的版税。预计这笔资金将支持这家生物技术公司开发多种疫苗，以弥补以 Spikevax 品牌销售的 COVID 疫苗销量的下降。Moderna计划在2024年投入约45亿美元用于研发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2422573982","title":"莫德纳盘中异动 急速上涨5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2422573982","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2422573982?lang=zh_cn&edition=full","pubTime":"2024-03-26 03:56","pubTimestamp":1711396565,"startTime":"0","endTime":"0","summary":"北京时间2024年03月26日03时56分，莫德纳股票出现异动，股价大幅拉升5.04%。截至发稿，该股报110.74美元/股，成交量294.81万股，换手率0.77%，振幅4.54%。机构评级方面，在所有26家参与评级的机构中，50%的券商给予买入建议，38%的券商给予持有建议，12%的券商给予卖出建议。莫德纳股票所在的生物技术行业中，整体跌幅为0.09%。截至 2023 年中期，莫德纳拥有处于临床试验中的39个mRNA开发候选物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403260356057a4eede5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403260356057a4eede5&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.modernatx.com","stockEarnings":[{"period":"1week","weight":0.0395},{"period":"1month","weight":0.0233},{"period":"3month","weight":0.0671},{"period":"6month","weight":0.42},{"period":"1year","weight":-0.219},{"period":"ytd","weight":0.0849}],"compareEarnings":[{"period":"1week","weight":0.0042},{"period":"1month","weight":-0.0299},{"period":"3month","weight":0.0417},{"period":"6month","weight":0.2257},{"period":"1year","weight":0.2254},{"period":"ytd","weight":0.0638}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Moderna, Inc.于2016年7月22日根据特拉华州法律注册成立。该公司是信使核糖核酸（信使核糖核酸）医学领域的领导者。通过在科学、技术和健康的交叉领域工作十多年，该公司以前所未有的速度和效率开发出药物，包括最早和最有效的新冠疫苗之一。该公司的mRNA平台已使传染病、免疫肿瘤学、罕见病和自身免疫性疾病的疗法和疫苗的开发成为可能。凭借独特的文化和由Moderna价值观和思维模式驱动的全球化团队，以负责任的方式改变人类健康的未来，该公司努力通过mRNA药物向人们传递尽可能大的影响。","yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":0.076025},{"month":2,"riseRate":0.333333,"avgChangeRate":0.021347},{"month":3,"riseRate":0.666667,"avgChangeRate":0.047414},{"month":4,"riseRate":0.666667,"avgChangeRate":0.139712},{"month":5,"riseRate":0.6,"avgChangeRate":0.042487},{"month":6,"riseRate":0.4,"avgChangeRate":-0.009402},{"month":7,"riseRate":0.6,"avgChangeRate":0.134145},{"month":8,"riseRate":0.4,"avgChangeRate":-0.018231},{"month":9,"riseRate":0.6,"avgChangeRate":-0.013683},{"month":10,"riseRate":0.4,"avgChangeRate":-0.018111},{"month":11,"riseRate":1,"avgChangeRate":0.338665},{"month":12,"riseRate":0.4,"avgChangeRate":-0.066731}],"exchange":"NASDAQ","name":"Moderna, Inc.","nameEN":"Moderna, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Moderna, Inc.(MRNA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Moderna, Inc.(MRNA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Moderna, Inc.,MRNA,Moderna, Inc.股票,Moderna, Inc.股票老虎,Moderna, Inc.股票老虎国际,Moderna, Inc.行情,Moderna, Inc.股票行情,Moderna, Inc.股价,Moderna, Inc.股市,Moderna, Inc.股票价格,Moderna, Inc.股票交易,Moderna, Inc.股票购买,Moderna, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Moderna, Inc.(MRNA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Moderna, Inc.(MRNA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}